New York State Common Retirement Fund
EWTX icon

New York State Common Retirement Fund’s Edgewise Therapeutics EWTX Stock Holding History

New York State Common Retirement Fund’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Sell
80,197
-8,740
-10% -$301K ﹤0.01% 1263
2026
Q1 		$2.8M Hold
88,937
– – ﹤0.01% 1249
2025
Q4 		$2.21M Buy
88,937
+5,500
+7% +$110K ﹤0.01% 1359
2025
Q3 		$1.35M Sell
83,437
-10,371
-11% -$147K ﹤0.01% 1577
2025
Q2 		$1.23M Buy
93,808
+22,358
+31% +$322K ﹤0.01% 1594
2025
Q1 		$1.57M Buy
71,450
+84
+0.1% +$2.2K ﹤0.01% 1469
2024
Q4 		$1.91M Buy
71,366
+4,284
+6% +$136K ﹤0.01% 1439
2024
Q3 		$1.79M Buy
67,082
+37,236
+125% +$741K ﹤0.01% 1446
2024
Q2 		$538K Sell
29,846
-38,852
-57% -$678K ﹤0.01% 2019
2024
Q1 		$1.25M Sell
68,698
-1,995
-3% -$31.7K ﹤0.01% 1675
2023
Q4 		$773K Buy
70,693
+26,822
+61% +$188K ﹤0.01% 1908
2023
Q3 		$251K Buy
43,871
+30,522
+229% +$207K ﹤0.01% 2322
2023
Q2 		$103K Sell
13,349
-35
-0.3% -$295 ﹤0.01% 2798
2023
Q1 		$89.3K Sell
13,384
-10,731
-44% -$99.5K ﹤0.01% 2842
2022
Q4 		$216K Buy
24,115
+8,090
+50% +$75.8K ﹤0.01% 2693
2022
Q3 		$158K Hold
16,025
– – ﹤0.01% 2852
2022
Q2 		$128K Sell
16,025
-12,149
-43% -$91.8K ﹤0.01% 2983
2022
Q1 		$273K Buy
28,174
+9,714
+53% +$125K ﹤0.01% 2687
2021
Q4 		$282K Buy
18,460
+7,735
+72% +$139K ﹤0.01% 2735
2021
Q3 		$178K Buy
10,725
+125
+1% +$2.26K ﹤0.01% 2949
2021
Q2 		$226K Buy
+10,600
New +$290K ﹤0.01% 2996

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

New York State Common Retirement Fund's EWTX Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Edgewise Therapeutics (EWTX) stake by 9.8% in Q2 2026, selling an estimated $301K and leaving 80,197 shares worth $3.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1263.

New York State Common Retirement Fund first reported a position in EWTX in Q2 2021 and has held it in 21 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • New York State Common Retirement Fund held 80,197 shares of Edgewise Therapeutics worth $3.26M as of Q2 2026.
  • New York State Common Retirement Fund sold 8,740 Edgewise Therapeutics shares in Q2 2026, an estimated $301K.
  • Edgewise Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1263 holding.
  • New York State Common Retirement Fund first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.